LinkinVax
LinKinVax operates as a clinical-stage biotechnology company.
LinkinVax has raised €11M across 2 funding rounds from 8 investors, most recently a round in Jan 2023. Based in Paris, France; active in Healthtech. Data as of 28 Oct 2026.
Paris, Francewww.linkinvax.com ↗
Total raised
€11M
€11,110,108
Funding rounds
2
Investors
8
distinct backers
Active since
2022-02
latest 2023-01
Funding by year
EUR raised per yearLinkinVax — funding by year — interactive chart.
Data table
| LinkinVax — funding by year | |
|---|---|
| 2022 | €3.8M |
| 2023 | €7.3M |
Signals
High confidenceRaise-next likelihood7
base rate 30% for Other
- ▼ Past typical raise window
- ▲ Up-round momentum
Exit likelihood8
base rate 11% (2+ rounds)
- ▼ No recent equity round (debt-only or quiet)
Timing: overdue vs cohort gap · momentum up. Funding-only estimates, not predictions and not investment advice — see signals.
Funding rounds
2 rounds| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2023-01-10 | Other | €7.3M | André-Jacques Auberton-Hervé,In-Q-Tel | View deal → |
| 2022-02-11 | Seed | €3.8M | Alain Tingaud,André-Jacques Auberton-Hervé,Geoffrey Duyk,Giorgio Anania,Jean-Paul Kress,Rémi Gaston - Dreyfus | View deal → |
Investors
8Related news
- LinKinVax Raises €7.3M in Fundingfinsmes.com · 2023-01
- finsmes.com
Similar companies
same sector or country- Mistral AI€6.5BFrance · AI
- Automotive Cells Company (ACC)€4.4BFrance · Transportation
- Philips€2.6BNetherlands · Healthtech
- Verkor€2.4BFrance · Energy
- Isomorphic Labs€2.3BUK · Healthtech
- CMR Surgical€1.5BUK · Healthtech
Global coverage: FundingData